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Abstract
Background:  Dialysis disequilibrium syndrome (DDS) is the clinical phenomenon of acute
neurologic symptoms attributed to cerebral edema that occurs during or following intermittent
hemodialysis (HD). We describe a case of DDS-induced cerebral edema that resulted in
irreversible brain injury and death following acute HD and review the relevant literature of the
association of DDS and HD.
Case Presentation: A 22-year-old male with obstructive uropathy presented to hospital with
severe sepsis syndrome secondary to pneumonia. Laboratory investigations included a pH of 6.95,
PaCO2 10 mmHg, HCO3 2 mmol/L, serum sodium 132 mmol/L, serum osmolality 330 mosmol/kg,
and urea 130 mg/dL (46.7 mmol/L). Diagnostic imaging demonstrated multifocal pneumonia,
bilateral hydronephrosis and bladder wall thickening. During HD the patient became progressively
obtunded. Repeat laboratory investigations showed pH 7.36, HCO3 19 mmol/L, potassium 1.8
mmol/L, and urea 38.4 mg/dL (13.7 mmol/L) (urea-reduction-ratio 71%). Following HD,
spontaneous movements were absent with no pupillary or brainstem reflexes. Head CT-scan
showed diffuse cerebral edema with effacement of basal cisterns and generalized loss of gray-white
differentiation. Brain death was declared.
Conclusions: Death is a rare consequence of DDS in adults following HD. Several features may
have predisposed this patient to DDS including: central nervous system adaptations from chronic
kidney disease with efficient serum urea removal and correction of serum hyperosmolality; severe
cerebral intracellular acidosis; relative hypercapnea; and post-HD hemodynamic instability with
compounded cerebral ischemia.
Published: 19 August 2004
BMC Nephrology 2004, 5:9 doi:10.1186/1471-2369-5-9
Received: 21 May 2004
Accepted: 19 August 2004
This article is available from: http://www.biomedcentral.com/1471-2369/5/9
© 2004 Bagshaw et al; licensee BioMed Central Ltd. 
This is an open-access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.BMC Nephrology 2004, 5:9 http://www.biomedcentral.com/1471-2369/5/9
Page 2 of 5
(page number not for citation purposes)
Background
Acute renal failure requiring hemodialysis (HD) is a com-
mon clinical problem in critically ill patients that is inde-
pendently associated with increased mortality[1]. Dialysis
disequilibrium syndrome (DDS) is the clinical phenome-
non of acute central nervous system dysfunction attrib-
uted to cerebral edema that occurs during or following
HD. The precise epidemiology of DDS is poorly
defined[2]. Review of MEDLINE (January 1966 – March
2004) suggested that DDS in critically ill patients has
rarely been reported[3,4]. We report a case of DDS-
induced cerebral edema that resulted in irreversible brain
injury and death following acute HD. Further, we review
the relevant literature of the association of DDS and HD.
Case presentation
A 22-year-old homosexual male presented to hospital
with progressive dyspnea, productive cough, generalized
malaise and fever. He had a known history of intravenous
cocaine abuse and recent serology in prior 3 months was
negative for human immunodeficiency virus (HIV).
Results of a physical examination showed signs of tachyp-
nea, tachycardia, accessory muscle use and left lung base
crackles. Tympanic temperature was 34.7°C. The remain-
der of the examination was unremarkable except for ure-
thral meatus stenosis.
Initial laboratory investigations are presented in Table 1.
Arterial blood gases showed pH of 6.95, PaCO2  10
mmHg, PaO2 109 mmHg, HCO3 2 mmol/L, and lactate
0.6 mmol/L consistent with high anion gap metabolic aci-
dosis with respiratory compensation. Serum creatinine
and blood urea nitrogen were 587 µmol/L and 46.7
mmol/L, respectively. Toxicology and drug screen was
negative. The metabolic acidosis was partially accounted
for by acute renal failure with retained unmeasured ani-
ons and ketonemia. Urinalysis showed pyuria. Electrocar-
diogram (ECG) showed normal sinus rhythm.
Chest radiograph revealed right middle lobe and lingular
patchy opacification. An abdomino-pelvic CT scan dem-
onstrated moderate to severe bilateral hydronephrosis,
bladder wall thickening with multiple diverticuli, and ret-
roperitoneal streaking consistent with acute infection. A
provisional diagnosis of severe sepsis was made with mul-
tiple potential foci of infection. The patient was given
empiric ceftriaxone, metronidazole and vancomycin. Spu-
tum specimen cultured heavy methicillin-sensitive Staphy-
lococcus aureus, blood cultures were positive for S. aureus,
Escherichia coli, and Group B Streptococcus. Urine cultured
greater than 108 CFU/L of multiple gram positive and neg-
ative organisms.
The patient was admitted to the intensive care unit (ICU).
The metabolic acidosis persisted (pH 7.00) a despite 100
mEq of 8.4% sodium bicarbonate bolus and infusion of
three liters of normal bicarbonate solution (150 mEq of
8.4% sodium bicarbonate in 1000 mL D5W). The patient
had a suprapubic bladder catheter inserted by angiogra-
phy. However, due to concern the patient remained olig-
uric following 4 L crystalloid resuscitation, hemodialysis
was organized. Hemodialysis parameters included: F160
membrane (surface area 1.5 m2  and KUf 50 mL/hr/
mmHg), dialysate sodium 136 mmol/L, potassium 3
mmol/L, calcium 1.25 mmol/L, bicarbonate 40 mmol/L,
and QD 500 mL/min, QB 250–300 mL/min via a 25 cm left
femoral double-lumen Uldall catheter. The patient had
71.5 L of blood processed over four hours with no fluid
removal. Although the patient was alert and appropriate
(Glasgow Coma Scale 15) with tachycardia and stable
normal range blood pressure before the initiation of dial-
ysis, he was demonstrating an increased work of breathing
and oxygen requirements suggestive of worsening sepsis
syndrome. Approximately 2.5 hrs after start of dialysis the
patient became rapidly unresponsive prompting intuba-
tion for airway protection. At completion of HD and over
the subsequent 4 hours the patient's neurologic status
deteriorated with evidence of loss of all brainstem
reflexes. Head CT-scan is shown in Figure 1.
Repeat laboratory investigations immediately following
hemodialysis revealed a pH 7.36, HCO3 19 mmol/L,
sodium 132 mmol/L, potassium 1.8 mmol/L, and urea
13.7 mmol/L (urea-reduction-ratio was 71%) (Table 1).
The patient rapidly progressed to refractory shock and
multi-organ dysfunction Diagnosis of brain death was
declared independently by an intensivist and a neurolo-
gist. At autopsy, the brain showed evidence of diffuse cer-
ebral edema. Cardiac assessment showed left ventricular
enlargement consistent with systemic hypertension likely
as a result of chronic kidney disease. Both lungs showed
patchy acute bronchopneumonia with edema and conges-
tion. Both kidneys appeared grossly pyonephrotic with
dilated, thickened ureters and suggested the presence of
acute on chronic pyelonephritis. The meatal aperture was
scarred and stenosed.
Discussion
The immediate indication for renal replacement therapy
was correction of refractory metabolic acidosis in the set-
ting of oliguria; however, following initiation of HD this
patient developed irreversible symptoms consistent with
DDS.
DDS occurs most commonly following initiation of
chronic HD for patients with end-stage renal disease[2].
Patients with pre-existing neurologic disease, such as head
trauma, stroke or malignant hypertension, may be at
greater risk for developing DDS[5,6]. The precise epidemi-BMC Nephrology 2004, 5:9 http://www.biomedcentral.com/1471-2369/5/9
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ology of DDS is poorly defined and may be under-
reported due to the wide spectrum of clinical manifesta-
tions. Mild symptoms such as headache, nausea, blurred
vision, muscle cramps, disorientation, anorexia, restless-
ness, hypertension and dizziness are common during or
following HD and may be attributed to DDS[2]. More
severe symptoms consistent with central nervous system
dysfunction such as seizures, central pontine myelinoly-
sis, coma and death are rare[7]. The temporal profile for
DDS is not well described. DDS has been credited for
acute electroencephalographic (EEG) abnormalities and
structural changes on diagnostic imaging following rapid
hemodialysis [8-10]. Likewise, brain MRI studies immedi-
ately following hemodialysis in chronic dialysis patients
have shown quantitative increases in brain volume con-
sistent with cerebral edema[11].
The pathogenesis remains debated and incompletely
understood; however, two central hypotheses have
emerged. First, acute urea removal occurs more slowly
across the blood-brain barrier than from plasma, generat-
ing a 'reverse osmotic gradient' promoting water move-
ment into the brain and cerebral edema[12]. Absolute
increases in brain water content have been demonstrated
in a rat model of uremia undergoing rapid hemodialysis
that was accounted for by an increase in the ratio of brain
to plasma urea[13,14]. Down-regulation of central nerv-
ous system urea transporters have been proposed as a
mechanism contributing to the delay in urea clearance
from the brain[15].
The second hypothesis states that the increased osmolality
of the extracellular fluid in uremia stimulates an adaptive
Table 1: Laboratory values at prior to and following initiation of hemodialysis in the intensive care unit.
Laboratory test Pre-dialysis Value Post-dialysis Values Reference range
Hemoglobin 96 78 137–180 g/L
White cell count 25.8 16.1 4.0–11.0 × 109/L
Band count 3.1 - 0.0–1.3 × 109/L
Platelets 603 486 150–400 × 109/L
Sodium 132 132 133–145 mmol/L
Potassium 3.1 1.8 3.5–5.0 mmol/L
Chloride 107 93 98–111 mmol/L
Bicarbonate 2 19 21–31 mmol/L
Glucose 6.3 9.0 3.6–11.1 mmol/L
Magnesium 0.88 0.57 0.65–1.15 mmol/L
Osmolality 330 - 280–300 mosmol/kg
Urea 46.7 13.7 3.0–7.6 mmol/L
Creatinine 537 - 61–111 µmol/L
Lactate 0.6 1.2 < 2.0 mmol/L
Serum ketones 2+ - Undetected
Anion gap 23 20 12–14
Osmolar gap 14.5 - 0–10
Computerized Tomography (CT) head showing diffuse cere- bral edema with effacement of basal cisterns and generalized  loss of gray-white differentiation Figure 1
Computerized Tomography (CT) head showing diffuse cere-
bral edema with effacement of basal cisterns and generalized 
loss of gray-white differentiationBMC Nephrology 2004, 5:9 http://www.biomedcentral.com/1471-2369/5/9
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accumulation of intracellular organic osmolytes to limit
cerebral cell dehydration[16]. During hemodialysis,
retention of these organic osmolytes contributes to a par-
adoxical reduction in intracellular pH resulting in
increased brain osmolality and cerebral edema[17,18].
The patient in this case unfortunately may have been sus-
ceptible to both proposed pathophysiologic mechanisms.
The likely and under-appreciated presence of pre-existing
kidney disease (chronic obstructive nephropathy and
pyelonephritis) with an increased serum osmolality
would have resulted in adaptive changes in the central
nervous system. Ensuing hemodialysis correction of the
plasma metabolic acidosis may have eclipsed a more
severe cerebral intracellular acidosis. Further, urea clear-
ance by hemodialysis was efficient at approximately 70%
and probably generated a sufficient plasma-to-brain urea
gradient for development of cerebral edema, intracranial
hypertension and DDS. A less efficient initial course of
hemodialysis would have diminished the osmolar gradi-
ent of urea across the central nervous system reducing the
likelihood of symptoms of DDS.
Other variables may have contributed. The patient was
compensating for the severe metabolic acidosis by hyper-
ventilation (PaCO2  10 mmHg); however, initial post-
intubation PaCO2 was 42 mmHg. Rapid elevations in
PaCO2 can alter cerebral autoregulation resulting in exac-
erbated intracranial hypertension[19]. Concomitant sep-
sis syndrome with poly-microbial bacteremia resulting in
widespread immune activation may alter blood-brain-
barrier permeability and contribute to cerebral
edema[20,21]. These factors likely contributed to an
increased risk for DDS-induced cerebral edema.
The symptoms of DDS have been ameliorated by several
interventions targeted to reduce the hemodialysis-
induced plasma-to-brain osmotic gradient promoting cer-
ebral edema[22]. A similar case of severe DDS requiring
intubation was prevented from recurring during subse-
quent hemodialysis by use of modified dialysate contain-
ing 10.1 mmol/L of urea[23]. Likewise, the
administration of intravenous mannitol and hyperventi-
lation reversed a case of severe DDS-induced central nerv-
ous system dysfunction in a patient undergoing initial
hemodialysis for acute renal failure[3]. Conversely,
sodium profiling, high sodium or hyperglycemic dialysate
have been attempted with variable results[24,25].
Prevention of DDS is traditionally the mainstay of ther-
apy, particularly during initiation of hemodialysis in new
patients. Despite the absence of evidence-based guide-
lines, the conventional aim is for a gradual clearance of
urea. This can be accomplished with intermittent hemodi-
alysis by use of a smaller, less efficient dialyzer and by
reducing the duration of initial dialysis to approximately
2 hours with targeted lower blood flow rates of 150–200
mL/min, use of sustained low-efficiency dialysis (SLED),
or initiation of continuous renal replacement therapy
(CRRT) with more gradual and stable clearance of
urea[2,26-28]. As a result, DDS has not been reported
with the use of SLED or CRRT in critically ill patients. By
providing a shorter, less efficient trial of initial hemodial-
ysis, the severe DDS and brain death in this case may have
been altogether prevented.
In summary, the precise epidemiology and pathophysiol-
ogy of DDS remain unclear. Although DDS usually
presents in end-stage renal disease patients undergoing
initial therapy, critically ill patients may represent a
unique population where co-existing illnesses such as sep-
sis, brain injury or other central nervous system disease,
multiorgan dysfunction, and need for sedation can
present obstacles for prompt diagnosis of DDS. Further-
more, for similar reasons, critically ill patients may have
increased susceptibility to DDS conditions.
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